Annual report on adverse events related with vaccines use in Calabria (Italy): 2012

被引:8
作者
Staltari, Orietta [1 ,2 ]
Cilurzo, Felisa [1 ,2 ]
Caroleo, Benedetto [1 ,2 ]
Greco, Alexia [1 ,2 ]
Corasaniti, Francesco [1 ,2 ]
Genovesi, Maria Antonietta [3 ]
Gallelli, Luca [1 ,2 ]
机构
[1] Univ Catanzaro, Ctr Reg Informaz Farmaco, Catanzaro, Italy
[2] Univ Catanzaro, Sch Med, Dept Hlth Sci, Catanzaro, Italy
[3] Azienda Sanitaria Provinciale Catanzaro, Catanzaro, Italy
关键词
Adverse events; Calabria; children; immunization; vaccines;
D O I
10.4103/0976-500X.120951
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Vaccines are administered to large population of healthy individuals, particularly to millions of infants every year, through national immunization programs. Although vaccines represent a good defense against some infectious diseases, their administration may be related with the development of adverse vaccine events (AVEs); therefore their use is continually monitored to detect these side effects. In the presents work, we reported the suspected AVEs recorded in 2012 in Calabria, Italy. We performed a retrospective study on report forms of patients that developed AVEs in Calabria from January 1, 2012 to December 31, 2012. Naranjo score was used to evaluate the association between AVEs and vaccines and only suspected AVEs definable as certain, probable, or possible were included in this analysis. During the study period, we evaluated 461 records of adverse drug reactions (ADRs) and 18 (3.9%) were probably induced by vaccination. AVEs were common in females (almost 77.7%) and in children aged 0-3 years. The largest number of non-serious AVEs involved "skin and subcutaneous tissue disorders" and "general disorders and administration site conditions." In conclusion, we documented that in Calabria the total number of AVEs is very low and it may be useful to increase the pharmacovigilance culture in order to evaluate the safety of these products in large populations.
引用
收藏
页码:S61 / S65
页数:5
相关论文
共 29 条
[1]   Adverse events following immunization in children: retrospective analysis of spontaneous reports over a decade [J].
Aagaard, Lise ;
Hansen, Erik Wind ;
Hansen, Ebba Holme .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (03) :283-288
[2]  
[Anonymous], 1999, Pediatr Infect Dis J, V18, P217
[3]   Pharmacovigilance of vaccines [J].
Autret-Leca, E ;
Bensouda-Grimaldi, L ;
Jonville-Béra, AP ;
Beau-Salinas, F .
ARCHIVES DE PEDIATRIE, 2006, 13 (02) :175-180
[4]   The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine [J].
Barlow, WE ;
Davis, RL ;
Glasser, JW ;
Rhodes, PH ;
Thompson, RS ;
Mullooly, JP ;
Black, SB ;
Shinefield, HR ;
Ward, JI ;
Marcy, SM ;
DeStefano, F ;
Chen, RT ;
Immanuel, V ;
Pearson, JA ;
Vadheim, CM ;
Rebolledo, V ;
Christakis, D ;
Benson, PJ ;
Lewis, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (09) :656-661
[5]  
Benkirane Raja R, 2009, J Patient Saf, V5, P16, DOI 10.1097/PTS.0b013e3181990d51
[6]   Association between Drug and Vaccine Use and Acute Immune Thrombocytopenia in Childhood A Case-Control Study in Italy [J].
Bertuola, Federica ;
Morando, Carla ;
Menniti-Ippolito, Francesca ;
Da Cas, Roberto ;
Capuano, Annalisa ;
Perilongo, Giorgio ;
Da Dalt, Liviana .
DRUG SAFETY, 2010, 33 (01) :65-72
[7]   COMPARISON OF 2 RECENTLY PUBLISHED ALGORITHMS FOR ASSESSING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].
BUSTO, U ;
NARANJO, CA ;
SELLERS, EM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (02) :223-227
[8]  
Centers for Disease Control and Prevention, 1997, EP PREV VACC PREV DI
[9]   THE VACCINE-ADVERSE-EVENT-REPORTING-SYSTEM (VAERS) [J].
CHEN, RT ;
RASTOGI, SC ;
MULLEN, JR ;
HAYES, SW ;
COCHI, SL ;
DONLON, JA ;
WASSILAK, SG .
VACCINE, 1994, 12 (06) :542-550
[10]   Vaccine safety: Current and future challenges [J].
Chen, RT ;
Hibbs, B .
PEDIATRIC ANNALS, 1998, 27 (07) :445-455